Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHR 160 Spray in COVID-19
NCT04463420Phase 2Unknown
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Aug 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing PHR 160 Arm with Placebo Arm (2 arms). Primary endpoint: Dyspnea at 14 days. Status: unknown.
02
Drugs
PHR 160
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04463420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04463420.